Vaginal Gel May Prevent HIV

Links shared publicly online about this topic.

  • 1,010
    total visits

Vaginal Gel May Prevent HIV

webmd.com

After 20 years of failure, AIDS researchers have finally found a vaginal gel that halves a woman's risk of getting HIV from an infected sex partner, research shows.

View full resource at webmd.com

Tags: HIV, AIDS, STD, Sex and Intimacy, Women's Health

  • Share

Most Recently Shared on July 19, 2010 at 10:25 pm By:

Also Shared By:

WebMD_News WebMD_News

HIV trial scrapped after gel found to be ineffective - Boston.com

boston.com — “In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.View full resource at boston.com

  • View Related
  • Share

Most Recently Shared on November 28, 2011 at 11:21 pm By:

HIV_Wisdom OrganizedWisdom HIV OW Health

HIV trial scrapped after gel found to be ineffective: In a major setback for AIDS prevention research, a clinica... http://t.co/GlJFvSlK

6 months ago...

HIV prevention trial ends in disappointment - chicagotribune.com

chicagotribune.com — “The microbicidal vaginal gel, tenofovir, does not prevent HIV infection from infected males to uninfected females, study shows.View full resource at chicagotribune.com

  • View Related
  • Share

Most Recently Shared on November 28, 2011 at 8:18 pm By:

AIDSmeds - Top Stories : Tenofovir Microbicide Gel Falters in Major HIV Prevention Study

aidsmeds.com — “HIV prevention efforts have suffered a major setback following a Microbicide Trials Network (MTN) announcement that a vaginal gel containing the antiretroviral tenofovir has been dropped from a large ongoing clinical trial because of lackluster effectiveness. The decision to discontinue the microbicide in the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study was unexpected and contradicts the optimistic results of an earlier study of the same tenofovir-based gel.View full resource at aidsmeds.com

  • View Related
  • Share

Most Recently Shared on November 28, 2011 at 5:25 pm By:

AIDSmeds AIDSmeds Health News

Top Stories : Tenofovir Microbicide Gel Falters in Major #HIV Prevention Study http://t.co/jokD5p2g #CAPRISA #VOICES #AIDS

6 months ago...

HIV Vaginal Gel Dropped From Study - Not Effective, Trial Review Found

medicalnewstoday.com — “A tenofovir-containing microbicide vaginal gel aimed at preventing sexual transmission of HIV in females has been dropped from the VOICE trial after a routine study data review concluded that it wView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 28, 2011 at 4:05 pm By:

mnt_healthnews MNT Health News Health News

HIV Vaginal Gel Dropped From Study - Not Effective, Trial Review Found http://t.co/h2S4o9L7 #healthnews

6 months ago...

AIDSmeds - Top Stories : Two-Drug Vaginal HIV Microbicide Ring Enters U.S. Safety Study

aidsmeds.com — “For the first time ever, researchers are conducting a clinical trial evaluating the safety of a vaginal ring combining two antiretroviral (ARV) medications that may prove to be more effective and easier to use than microbicide gels.View full resource at aidsmeds.com

  • View Related
  • Share

Most Recently Shared on November 18, 2011 at 2:40 pm By:

AIDSmeds AIDSmeds Health News

Top Stories : Two-Drug Vaginal #HIV Microbicide Ring Enters U.S. Safety Study http://t.co/zWHdI4Uk #AIDS

6 months ago...

Oral tenofovir discontinued in HIV clinical trial

news-medical.net — “A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 29, 2011 at 2:20 pm By:

HIVAIDS_News News-Medical.Net Health News

HIV/AIDS News: Oral tenofovir discontinued in HIV clinical trial: A large-scale clinical trial evaluating whethe... http://t.co/uQ64lH9y

8 months ago...

Development Of A Vaginal Gel And PrEP Lead To Calls For A Combination Of Biomedical And Non Biomedical Approaches To HIV Prevention Policy

medicalnewstoday.com — “Researchers speaking in the first plenary session of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have offered insights into current and future HIV prevention reView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 19, 2011 at 9:05 am By:

mnt_preventmed MNT Preventive Med Health News

Development Of A Vaginal Gel And PrEP Lead To Calls For A Combination Of Biomedical And Non Biomedical Approaches To H... http://mnt.to/3YmD

10 months ago...

Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy

eurekalert.org — “Researchers speaking in the first plenary session of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention have today offered insights into current and future HIV prevention research and discussed how biomedical developments over the past two years are beginning to shape debate on the future of HIV prevention policy.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on July 18, 2011 at 6:49 pm By:

HIV_Wisdom OrganizedWisdom HIV OW Health

Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combinatio... http://bit.ly/npEO8l

11 months ago...

VOICE study will continue as it considers what action to take after results of 2 trials

eurekalert.org — “Today, researchers from two major HIV prevention trials announced favorable results of an approach called pre-exposure prophylaxis (PrEP), which involves the use of drugs commonly used for treating HIV. One of these, the Partners PrEP study, provides the strongest evidence yet of PrEP's effectiveness. A full evaluation is needed to determine the best course for VOICE, an ongoing study of more than 5,000 women in sub-Saharan Africa testing both PrEP and the vaginal microbicide tenofovir gel.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on July 14, 2011 at 12:13 am By:

WomensHealth_OW Women's Health OW OW Health

VOICE study will continue as it considers what action to take after results of 2 trials: ( Microbicide Trials Ne... http://bit.ly/nYSHhE

11 months ago...

Anti-HIV gel being evaluated in pregnant and breastfeeding women

eurekalert.org — “Determining whether a promising HIV prevention gel is safe for women to use while pregnant or breastfeeding is the aim of a new clinical trial being conducted by the Microbicide Trials Network (MTN). Researchers are hopeful that the study of the vaginal microbicide tenofovir gel--the first in breastfeeding women and only the second in pregnancy--will bring them closer to developing a safe and effective HIV prevention product women can use throughout their lives.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on June 21, 2011 at 2:28 am By:

HIV_Wisdom OrganizedWisdom HIV OW Health

Anti-HIV gel being evaluated in pregnant and breastfeeding women: ( Microbicide Trials Network ) Determining whe... http://bit.ly/kekQVB

11 months ago...

Tenofovir vaginal gel reformulated for rectal use - News - Virtual Medical Centre

virtualmedicalcentre.com — “A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum.View full resource at virtualmedicalcentre.com

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 1:06 pm By:

Tenofovir gel provides high level of protection against HIV in rectal tissue

new.eurekalert.org — “A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study. The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel could help reduce the risk of HIV from anal sex, even though the vaginal gel formulation may not be optimal for rectal use.View full resource at new.eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 9, 2011 at 8:29 am By:

HIV_Wisdom OrganizedWisdom HIV OW Health

Tenofovir gel provides high level of protection against HIV in rectal tissue: ( Microbicide Trials Network ) A g... http://bit.ly/g4cHTz

1 year ago...

VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel

medicalnewstoday.com — “In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vaginaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 8:54 pm By:

HIV_Wisdom OrganizedWisdom HIV OW Health

VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel: In the first ... http://bit.ly/fsitlG

1 year ago...

A Vaginal Anti-HIV Gel May Protect Anal Tissue Cells from Infection - TIME Healthland

healthland.time.com — “A new study presented Monday at the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston suggested the potential of an anti-HIV gel in protecting rectal tissue cells from infection with the virus that causes AIDS. The gel made by Gilead Sciences Inc.View full resource at healthland.time.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 2:57 pm By:

MFHS1 MFHS.org Health Organization

Interesting study on an anti-HIV gel in Time: http://ow.ly/45yFw

1 year ago...

VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel

medicalnewstoday.com — “In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vaginaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 1:54 pm By:

OralHealth_OW Oral Health OW OW Health

VOICE - Vaginal And Oral Interventions To Control The Epidemic Of HIV Looks At Tablets Versus Gel: In the first ... http://bit.ly/dZ2Wri

1 year ago...

Advertisement